A five day course covering the biology, science and mechanisms behind the diverse range of targeted drug treatments and new immunotherapies for cancer with an overview of how they work – focusing on the science behind them – and giving descriptions of which treatments are relevant to each of the most common solid tumours and haematological cancers.